|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
||||||||||||||
|
||||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s6D9A6E1A-5CB8-11EF-85AD-1BDC84CE164B&I=39IZM&T=&OP=Display&O=html&O1=15432290&O2=1000000000543550&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DAntibody-enzyme%2520fusion%2520proteins%2520for%2520cancer%2520therapy%26rft.au%3DAndrady%252C%2520Carima%26rft.au%3DChester%252C%2520Kerry%2520A%26rft.au%3DSharma%252C%2520Surinder%2520K%26rft.date%3D2011-02-01%26rft.eissn%3D1750-7448%26rft.externalDocID%3D21322759%26rft.genre%3Darticle%26rft.issue%3D2%26rft.jtitle%3DImmunotherapy%26rft.spage%3D193%26rft.volume%3D3%26rft_id%3Dinfo%253Adoi%252F10.2217%252Fimt.10.90%26rft_id%3Dinfo%253Apmid%252F21322759%26rft_id%3Dinfo%253Apmid%252F21322759%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-PROQUEST_CENTRAL-getFullTxt-object,2-DOI-getDOI-object,3-COBIB_SI_LCL-getHolding-object,4-ELSEVIER_SCOPUS_FIS_LCL-getAbstract-object,5-ISI_JOURNAL_CITATION_REPORTS_SCIENCE_EDITION-getCitedJournal-object,6-REFWORKS_EXPORT_TOOL-getReference-object,7-NCBI_PUBMED_FREE-getCitedRecord-object,8-SHERPA_RoMEO_LCL-getWebService-object,9-GOOGLE_SCHOLAR_FREE-getWebSearch-object,10-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=2.207545&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:15432290-s6D9A6E1A-5CB8-11EF-85AD-1BDC84CE164B" timestamp="2024-08-17T18:47:49Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:1000000000543550</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Antibody–Enzyme Fusion Proteins for Cancer Therapy</jnl:atitle>
<jnl:jtitle>Immunotherapy</jnl:jtitle>
<jnl:date>2011-02-15</jnl:date>
<jnl:spage>193</jnl:spage>
<jnl:epage>211</jnl:epage>
<jnl:issn>1750-743X</jnl:issn>
<jnl:volume>3</jnl:volume>
<jnl:issue>2</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>1750-7448</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:37276f06ac147dc1999ff9c83166aa0985ffe450</ctx:identifier>
<ctx:identifier>urn:UUID:s6D9A6E1A-5CB8-11EF-85AD-1BDC84CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)